Federal Court of Australia
Stephane Chatonsky is a seasoned professional with extensive experience in leadership and advisory roles across various sectors, including medical technology and investment. Currently serving as a Non Executive Director at Neo-Bionica, Cerulea Clinical Trials, Drop Bio Health, and as Board Chair at Brainmates, Stephane leverages expertise in product management and clinical trial oversight. Other roles include Chair of Syndicate groups at The CEO Institute, Co-Founder and Managing Director of IVEST, Expert Witness for the Federal Court of Australia, and Adjunct Faculty at The University of Queensland. Stephane holds an M.B.A. from The Wharton School and multiple executive education credentials from prestigious institutions such as INSEAD and Harvard Business School.
This person is not in the org chart
This person is not in any teams
Federal Court of Australia
The Federal Court was created by the Federal Court of Australia Act 1976 and began to exercise its jurisdiction on 1 February 1977. It assumed jurisdiction formerly exercised in part by the High Court of Australia and the whole jurisdiction of the Australian Industrial Court and the Federal Court of Bankruptcy. The Court is a superior court of record and a court of law and equity. It sits in all capital cities and elsewhere in Australia from time to time.